Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 905

1.

Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression.

Majbour NK, Vaikath NN, Eusebi P, Chiasserini D, Ardah M, Varghese S, Haque ME, Tokuda T, Auinger P, Calabresi P, Parnetti L, El-Agnaf OM.

Mov Disord. 2016 Aug 22. doi: 10.1002/mds.26754. [Epub ahead of print]

PMID:
27548849
2.

20/40 or Better Visual Acuity After Optic Neuritis: Not as Good as We Once Thought?

Sabadia SB, Nolan RC, Galetta KM, Narayana KM, Wilson JA, Calabresi PA, Frohman EM, Galetta SL, Balcer LJ.

J Neuroophthalmol. 2016 Jul 28. [Epub ahead of print]

PMID:
27472185
3.

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Golan D, Miller A, Sotirchos ES, Bhargava P, Calabresi PA.

Neurology. 2016 Jul 26;87(4):446. doi: 10.1212/01.wnl.0000490142.79912.ff. No abstract available.

PMID:
27462040
4.

Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.

Avasarala J, Sotirchos ES, Bhargava P, Calabresi PA.

Neurology. 2016 Jul 26;87(4):445-6. doi: 10.1212/WNL.0000000000002937. No abstract available.

PMID:
27462039
5.

Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.

Chiasserini D, Biscetti L, Farotti L, Eusebi P, Salvadori N, Lisetti V, Baschieri F, Chipi E, Frattini G, Stoops E, Vanderstichele H, Calabresi P, Parnetti L.

J Alzheimers Dis. 2016 Jul 22. [Epub ahead of print]

PMID:
27447425
6.

Extracranial Venous Drainage Pattern in Multiple Sclerosis and Healthy Controls: Application of the 2011 Diagnostic Criteria for Chronic Cerebrospinal Venous Insufficiency.

Cardaioli G, Di Filippo M, Bianchi A, Eusebi P, Di Gregorio M, Gaetani L, Gallina A, Calabresi P, Sarchielli P.

Eur Neurol. 2016;76(1-2):62-8. doi: 10.1159/000445540. Epub 2016 Jul 7.

PMID:
27384420
7.

Hyperkinetic disorders and loss of synaptic downscaling.

Calabresi P, Pisani A, Rothwell J, Ghiglieri V, Obeso JA, Picconi B.

Nat Neurosci. 2016 Jun 28;19(7):868-75. doi: 10.1038/nn.4306.

PMID:
27351172
8.

Is my MS patient failing treatment?

Butzkueven H, Calabresi PA.

Neurology. 2016 Jul 12;87(2):124-5. doi: 10.1212/WNL.0000000000002851. Epub 2016 Jun 15. No abstract available.

PMID:
27306627
9.

Diagnostic utility of CSF α-synuclein species in Parkinson's disease: protocol for a systematic review and meta-analysis.

Eusebi P, Giannandrea D, Biscetti L, Abraha I, Chiasserini D, Orso M, Calabresi P, Parnetti L.

BMJ Open. 2016 Jun 13;6(6):e011113. doi: 10.1136/bmjopen-2016-011113.

10.

A53T in a parkinsonian family: a clinical update of the SNCA phenotypes.

Tambasco N, Nigro P, Romoli M, Prontera P, Simoni S, Calabresi P.

J Neural Transm (Vienna). 2016 Jun 1. [Epub ahead of print]

PMID:
27250986
11.

Biomarkers in Parkinson's disease: From pathophysiology to early diagnosis.

Calabresi P, Standaert DG, Chiasserini D, Parnetti L.

Mov Disord. 2016 Jun;31(6):769-70. doi: 10.1002/mds.26683. No abstract available.

PMID:
27245116
12.

Combined registration and motion correction of longitudinal retinal OCT data.

Lang A, Carass A, Al-Louzi O, Bhargava P, Solomon SD, Calabresi PA, Prince JL.

Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9784. pii: 97840X. Epub 2016 Mar 21.

13.

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies.

Cruz-Herranz A, Balk LJ, Oberwahrenbrock T, Saidha S, Martinez-Lapiscina EH, Lagreze WA, Schuman JS, Villoslada P, Calabresi P, Balcer L, Petzold A, Green AJ, Paul F, Brandt AU, Albrecht P; IMSVISUAL consortium.

Neurology. 2016 Jun 14;86(24):2303-9. doi: 10.1212/WNL.0000000000002774. Epub 2016 May 25. Review.

14.

Voxel Based Morphometry in Optical Coherence Tomography: Validation & Core Findings.

Antony BJ, Chen M, Carass A, Jedynak BM, Al-Louzi O, Solomon SD, Saidha S, Calabresi PA, Prince JL.

Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9788. pii: 97880P. Epub 2016 Mar 29.

15.

Simultaneous Segmentation of Retinal Surfaces and Microcystic Macular Edema in SDOCT Volumes.

Antony BJ, Lang A, Swingle EK, Al-Louzi O, Carass A, Solomon S, Calabresi PA, Saidha S, Prince JL.

Proc SPIE Int Soc Opt Eng. 2016 Feb 27;9784. pii: 97841C. Epub 2016 Mar 21.

16.

Early synaptic dysfunction in Parkinson's disease: Insights from animal models.

Schirinzi T, Madeo G, Martella G, Maltese M, Picconi B, Calabresi P, Pisani A.

Mov Disord. 2016 Jun;31(6):802-13. doi: 10.1002/mds.26620. Epub 2016 May 19. Review.

PMID:
27193205
17.

Pharmacological enhancement of mGlu5 receptors rescues behavioral deficits in SHANK3 knock-out mice.

Vicidomini C, Ponzoni L, Lim D, Schmeisser MJ, Reim D, Morello N, Orellana D, Tozzi A, Durante V, Scalmani P, Mantegazza M, Genazzani AA, Giustetto M, Sala M, Calabresi P, Boeckers TM, Sala C, Verpelli C.

Mol Psychiatry. 2016 Apr 26. doi: 10.1038/mp.2016.70. [Epub ahead of print] No abstract available.

PMID:
27113996
18.

Multiple sclerosis and chronic progressive external ophthalmoplegia associated with a large scale mitochondrial DNA single deletion.

Gaetani L, Mignarri A, Di Gregorio M, Sarchielli P, Malandrini A, Cardaioli E, Calabresi P, Dotti MT, Di Filippo M.

J Neurol. 2016 Jul;263(7):1449-51. doi: 10.1007/s00415-016-8120-5. Epub 2016 Apr 25. No abstract available.

PMID:
27113600
19.

Increased TNFR1 expression and signaling in injured peripheral nerves of mice with reduced BACE1 activity.

Liu L, Fissel JA, Tasnim A, Borzan J, Gocke A, Calabresi PA, Farah MH.

Neurobiol Dis. 2016 Sep;93:21-7. doi: 10.1016/j.nbd.2016.04.002. Epub 2016 Apr 11.

PMID:
27080468
20.

Erratum: Persistent activation of microglia and NADPH oxidase drive hippocampal dysfunction in experimental multiple sclerosis.

Di Filippo M, de Iure A, Giampà C, Chiasserini D, Tozzi A, Orvietani PL, Ghiglieri V, Tantucci M, Durante V, Quiroga-Varela A, Mancini A, Costa C, Sarchielli P, Fusco FR, Calabresi P.

Sci Rep. 2016 Apr 13;6:23855. doi: 10.1038/srep23855. No abstract available.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk